124 related articles for article (PubMed ID: 1450806)
21. 'Seronegative' Sjögren's syndrome manifested as a subset of chronic fatigue syndrome.
Nishikai M; Akiya K; Tojo T; Onoda N; Tani M; Shimizu K
Br J Rheumatol; 1996 May; 35(5):471-4. PubMed ID: 8646439
[TBL] [Abstract][Full Text] [Related]
22. Hypergammaglobulinemic purpura in patients with Sjögren's syndrome: a report of nine cases and a review of the Japanese literature.
Sugai S; Shimizu S; Tachibana J; Sawada M; Yoshioka R; Hirose Y; Takiguchi T; Konda S; Murayama T
Jpn J Med; 1989; 28(2):148-55. PubMed ID: 2659854
[TBL] [Abstract][Full Text] [Related]
23. Mixed connective tissue disease, Sjögren's syndrome, and abdominal pseudolymphoma.
Frayha RA; Nasr FW; Mufarrij AA
Br J Rheumatol; 1985 Feb; 24(1):70-3. PubMed ID: 3872150
[TBL] [Abstract][Full Text] [Related]
24. Immunological profiles determine neurological involvement in Sjögren's syndrome.
Jamilloux Y; Magy L; Hurtevent JF; Gondran G; de Seze J; Launay D; Ly KH; Lambert M; Hachulla E; Hatron PY; Vidal E; Fauchais AL
Eur J Intern Med; 2014 Feb; 25(2):177-81. PubMed ID: 24176941
[TBL] [Abstract][Full Text] [Related]
25. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
26. Primary Sjögren's syndrome and vitamin B12 deficiency: preliminary results in 80 patients.
Andrès E; Blicklé F; Sordet C; Cohen-Solal J; Sibilia J; Sapin R
Am J Med; 2006 Jun; 119(6):e9-10. PubMed ID: 16750953
[No Abstract] [Full Text] [Related]
27. [Association of Sjögren's syndrome and mixed connective tissue disease (Sharp's syndrome) in an adolescent (author's transl)].
Rouchon C; Ghozlan E; Laudenbach P; Briault F
Rev Stomatol Chir Maxillofac; 1978; 79(3):265-72. PubMed ID: 309169
[TBL] [Abstract][Full Text] [Related]
28. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
Alexander EL; Arnett FC; Provost TT; Stevens MB
Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
[TBL] [Abstract][Full Text] [Related]
29. [Sjögren's syndrome and vasculitis associated with antineutrophil cytoplasmic antibodies].
Lema Gontad JM; Espinosa Garriga G
Med Clin (Barc); 2012 Nov; 139(12):554-5. PubMed ID: 22766054
[No Abstract] [Full Text] [Related]
30. Clinical course of silent thyroiditis in a patient with Sjögren's syndrome. Concomitant changes of antithyroid antibodies and antinuclear antibody.
Mitani Y; Shigemasa C; Taniguchi S; Tanaka T; Yoshida A; Mashiba H
Arch Intern Med; 1988 Sep; 148(9):1974-5. PubMed ID: 3261973
[TBL] [Abstract][Full Text] [Related]
31. [Primary Sjögren's syndrome revealing cerebellar syndrome].
Meriglier E; Debouverie O; Walter-Lepage A; Brigaud A; Beuvon C; Luca L
Rev Neurol (Paris); 2015 Sep; 171(8-9):674-6. PubMed ID: 25912281
[No Abstract] [Full Text] [Related]
32. Development of complete heart block in an adult patient with Sjögren's syndrome and anti-Ro/SS-A autoantibodies.
Lee LA; Pickrell MB; Reichlin M
Arthritis Rheum; 1996 Aug; 39(8):1427-9. PubMed ID: 8702455
[TBL] [Abstract][Full Text] [Related]
33. A prospective immunofluorescence study of immune deposits in the skin of primary Sjögren's syndrome.
Velthuis PJ; Nieboer C; Kater L; Hené RJ
Acta Derm Venereol; 1989; 69(6):487-91. PubMed ID: 2575320
[TBL] [Abstract][Full Text] [Related]
34. Sjögren's syndrome and granulomatous panniculitis.
Tait CP; Yu LL; Rohr J
Australas J Dermatol; 2000 Aug; 41(3):187-9. PubMed ID: 10954994
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary manifestations of Sjögren's syndrome.
Cain HC; Noble PW; Matthay RA
Clin Chest Med; 1998 Dec; 19(4):687-99, viii. PubMed ID: 9917960
[TBL] [Abstract][Full Text] [Related]
36. Primary Sjögren's syndrome in patients with multiple sclerosis.
Sandberg-Wollheim M; Axéll T; Hansen BU; Henricsson V; Ingesson E; Jacobsson L; Larsson A; Lieberkind K; Manthorpe R
Neurology; 1992 Apr; 42(4):845-7. PubMed ID: 1565240
[TBL] [Abstract][Full Text] [Related]
37. The coexistence of Sjögren's syndrome and systemic lupus erythematosus.
Steinberg AD; Talal N
Ann Intern Med; 1971 Jan; 74(1):55-61. PubMed ID: 5312811
[No Abstract] [Full Text] [Related]
38. [Gougerot-Sjögren syndrome. Central neurological involvement with recurrent development].
Ménage P; de Toffol B; Degenne D; Saudeau D; Bardos P; Autret A
Rev Neurol (Paris); 1993; 149(10):554-6. PubMed ID: 8023070
[TBL] [Abstract][Full Text] [Related]
39. [Sjögren's syndrome and anti-SS.A, SS.B antibodies].
Azukizawa H; Kageyama K; Miyawaki S; Ofuji M
Nihon Rinsho; 1983; 41(1):212-6. PubMed ID: 6601731
[No Abstract] [Full Text] [Related]
40. Sjögren's syndrome: association with type-1 diabetes mellitus.
Binder A; Maddison PJ; Skinner P; Kurtz A; Isenberg DA
Br J Rheumatol; 1989 Dec; 28(6):518-20. PubMed ID: 2590806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
